New registry to keep track of vascular patients launched

Jan 31, 2020 Re-posted from the February 2020 issue of Vascular Specialist

A registry to track management of new patients who are being treated medically for a number of vascular diseases has been launched by the Society for Vascular Surgery (SVS) Patient Safety Organization® and the Society for Vascular Medicine, in collaboration with the American Heart Association, for the Vascular Quality Initiative (VQI).

The VQI, a joint venture of M2S Inc. and the SVS, collects and analyzes data in order to help improve the quality of vascular care.

The Vascular Medicine Consult (VMC) registry will emphasize medication details and dosages, both risk factor and lifestyle modifications, nonoperative treatments and counseling those being treated medically for atherosclerotic carotid artery occlusive disease, abdominal aortic aneurysm and peripheral lower extremity arterial disease due to atherosclerosis or true aneurysm.

VMC’s value centers on the comparative effectiveness of surgery versus medically managing these vascular diseases.

“We are extremely excited about the introduction of the Vascular Medicine Consult registry,” said Jens Jorgensen, MD, VQI medical director.

“The effort and collaboration put into the VMC will provide a necessary platform for physicians to manage, analyze and improve outcomes for patients with peripheral arterial disease being treated with medical therapy. Data generated by the registry will directly support our goal of improving care for medically managed patients.”

Watch a webinar on VMC at vsweb.org/VMCWebinar.

Tags
Vascular Specialist

Related Articles

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.

New SVS vice president, revised bylaws set to be unveiled at June 16 Annual Business Meeting

Members, be sure to register for the June 16 Virtual Annual Business Meeting, the first of two business meetings for 2021. Registration is required to assure A quorum. Register at vascular.org/ABM1Register. The second meeting will be held Saturday, Aug. 21, during the Vascular Annual Meeting (VAM). The Wednesday, June 16, meeting will be from 6 to 7 p.m. Central Daylight Time. Members will hear reports from President Ronald L. Dalman, MD, Secretary Amy Reed, MD, and Treasurer Keith Calligaro, MD. Nominating Committee Chair R. Clement Darling III, MD, will present his report, announce the results of the election for SVS vice president and on bylaws revisions, and introduce the 2021–22 Officers.